Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
Limin Zhao, Miao Zhang, Ze‐Lin Zhan, Mei Qiu
Abstract
OPINION article Front. Cardiovasc. Med., 05 May 2021 | https://doi.org/10.3389/fcvm.2021.679124
Topics & Concepts
MedicineType 2 diabetesAngiotensin Receptor BlockersRenin–angiotensin systemDiabetes mellitusLead (geology)Internal medicineCardiologyPharmacologyEndocrinologyBlood pressureGeologyGeomorphologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentPancreatic function and diabetes